Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Scar Prevention
NCT06437912Phase 1Completed
- Sponsor
- Qilu Hospital of Shandong University Dezhou Hospital
- Start
- Mar 2023
- Primary completion
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of botulinum toxin type A in scar (4 arms), sponsored by Qilu Hospital of Shandong University Dezhou Hospital. Primary endpoint: Modified Stony Brook Scar Evaluation Scale at 6 months. Started Mar 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
scar
Beyond the preview
Go deeper on NCT06437912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06437912.